\u3cem\u3eDarius\u3c/em\u3e

https://digitalcommons.imsa.edu/aesthetic_photo/1000/thumbnail.jp

New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries

The past decade has witnessed groundbreaking advances in the field of microbiome research. An area where immense implications of the microbiome have been demonstrated is tumor biology. The microbiome affects tumor initiation and progression through direct effects on the tumor cells and indirectly through manipulation of the immune system. It can also determine response to cancer therapies and predict disease progression and survival. Modulation of the microbiome can be harnessed to potentiate the efficacy of immunotherapies and decrease their toxicity. In this review, we comprehensively dissect recent evidence regarding the interaction of the microbiome and anti-tumor immune machinery and outline the critical questions which need to be addressed as we further explore this dynamic colloquy

Steady state and time resolved laser-induced fluorescence of garlic plants treated with titanium dioxide nanoparticles

<p>The study involves investigation of the effect of the interaction of titanium dioxide nanoparticles with garlic plant by spectroscopy techniques. For this, garlic plants have been grown in the laboratory under controlled conditions of light flux, temperature, humidity, and nutrient media. The growth and biomass parameters in terms of shoot length, fresh, and dry mass are found to increase upon the treatment of titanium dioxide nanoparticles while a reduction is observed in the root length of the garlic plants. The steady state laser-induced fluorescence, time resolved laser-induced fluorescence, and ultraviolet visible spectra of the control and titanium dioxide nanoparticles-treated plants have been acquired. The curve fitting data reveal that titanium dioxide nanoparticles decrease the intensity and fluorescence intensity ratio of red and far red chlorophyll fluorescence bands indicating increase in the photosynthetic activity and chlorophyll content. The evaluation of life time of the excited chlorophyll molecule shows that life time is effected by the treatment of the titanium dioxide nanoparticles. The results pertaining to ultraviolet visible measurement indicate increase in the concentration of chlorophyll a, chlorophyll b, total chlorophyll, carotenoid, and quercetin in the leaves of garlic plants treated with titanium dioxide nanoparticles.</p

Microbleed prevalence and burden in anticoagulant-associated intracerebral bleed

10.1002/acn3.50834ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY6

Optimization of risk stratification for anticoagulation-associated intracerebral hemorrhage: net risk estimation

BACKGROUND: Every anticoagulation decision has in inherent risk of hemorrhage; intracerebral hemorrhage (ICH) is the most devastating hemorrhagic complication. We examined whether combining ischemic and hemorrhagic stroke risk in individual patients might provide a meaningful paradigm for risk stratification. METHODS: We enrolled consecutive patients with anticoagulation-associated ICH in 15 tertiary centers in the USA, Europe and Asia between 2015 and 2017. Each patient was assigned baseline ischemic stroke and hemorrhage risk based on their CHA RESULTS: We enrolled 357 patients [59% men, median age 76 (68-82) years]. 31% used non-vitamin K antagonist (NOAC). 191 (53.5%) patients had a favorable indication for anticoagulation prior to their ICH; 166 (46.5%) unfavorable. Those with unfavorable indication were younger [72 (66-80) vs 78 (73-84) years, p = 0.001], with lower CHA CONCLUSIONS: In this anticoagulation-associated ICH cohort, baseline hemorrhagic risk exceeded ischemic risk in approximately 50%, highlighting the importance of careful consideration of risk/benefit ratio prior to anticoagulation decisions. The remaining 50% suffered an ICH despite excess baseline ischemic risk, stressing the need for biomarkers to allow more precise estimation of hemorrhagic complication risk

Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage

Background and Purpose- The aim of this study was to prospectively validate our prior findings of smaller hematoma volume and lesser neurological deficit in nonvitamin K oral anticoagulant (NOAC) compared with Vitamin K antagonist (VKA)-related intracerebral hemorrhage (ICH). Methods- Prospective 12-month observational study in 15 tertiary stroke centers in the United States, Europe, and Asia. Consecutive patients with premorbid modified Rankin Scale score ofvolume, significant hematoma expansion (absolute [12.5 mL] or relative [\u3e33%] increase), neurological severity measured by National Institutes of Health Stroke Scale score, 90-day mortality, and functional status (modified Rankin Scale score). Results- Our cohort comprised 196 patients, 62 NOAC related (mean age, 75.0±11.4 years; 54.8% men) and 134 VKA related (mean age, 72.3±10.5; 73.1% men). There were no differences in vascular comorbidities, antiplatelet, and statin use; NOAC-related ICH patients had lower median baseline hematoma volume (13.8 [2.5-37.6] versus 19.5 [6.6-52.0] mL; P=0.026) and were less likely to have severe neurological deficits (National Institutes of Health Stroke Scale score of \u3e10 points) on admission (37% versus 55.3%, P=0.025). VKA-ICH were more likely to have significant hematoma expansion (37.4% versus 17%, P=0.008). NOAC pretreatment was independently associated with smaller baseline hematoma volume (standardized linear regression coefficient:-0.415 [95% CI, -0.780 to -0.051]) resulting in lower likelihood of severe neurological deficit (odds ratio, 0.44; 95% CI, 0.22-0.85) in multivariable-adjusted models. Conclusions- Patients with NOAC-related ICH have smaller baseline hematoma volumes and lower odds of severe neurological deficit compared with VKA-related ICH. These findings are important for practicing clinicians making anticoagulation choices